Skip to content

Clinical trials

Scleroderma, Systemic trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Scleroderma, Systemic Country / region: Brazil Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20101
20111
20141
20151
20182
20221
20232
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting5
Unknown status2
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim3
Federal University of São Paulo3
University of Sao Paulo General Hospital3
Actelion1
Artiva Biotherapeutics, Inc.1
GlaxoSmithKline1
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company1
University of Sao Paulo1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Scleroderma, Systemic14
Arthritis, Rheumatoid6
Myositis5
Scleroderma, Diffuse5
Arthritis, Juvenile4
Dermatomyositis4
Lupus Erythematosus, Systemic4
Sjogren's Syndrome4
Spondylarthritis3
Antiphospholipid Syndrome2

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.